近日，剂泰医药（METiS Pharmaceuticals）接连亮相第39届癌症免疫治疗学会（SITC 2024）年会及第十二届International mRNA Health Conference，重磅展示了用于治疗晚期肝癌的创新核酸药物MTS105的临床前研究数据，赢得广泛关注。 在International mRNA Health Conference上，公司提交的壁报“Organ-Spe ...

Scientists from the University of Pennsylvania have developed an ideal “recipe” for ionizable lipids, which are essential ...

To enhance mRNA distribution, Penn engineers have created an ideal “recipe” for ionizable lipids, which are essential ...

RNA therapeutics promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will ...

Penn Engineers have cooked up a new way to improve mRNA delivery, developing an optimal "recipe" for ionizable lipids -; key ingredients in lipid nanoparticles (LNPs), the molecules behind the ...

Engineers have cooked up a new way to improve mRNA delivery, developing an optimal 'recipe' for ionizable lipids -- key ingredients in lipid nanoparticles (LNPs), the molecules behind the COVID-19 ...

Researchers have cooked up a new way to improve mRNA delivery, developing an optimal “recipe” for ionizable lipids — key ...

This lipid's structure influences the ability of LNPs to successfully deliver their contents and advances mRNA therapies for vaccines and gene editing. A Breakthrough in LNP Design Nanoparticles have ...

在针对 aCD71 抗体优化实验中，则发现最佳重链突变体 S92A 结合 IC50 达到 29 pM，进一步设计的多突变体结合 IC50 效率达到 19 pM，同时提升了抗体的表达水平和亲和力。